Proteome Sciences (LON:PRM) Trading Up 45.5% – What’s Next?

Proteome Sciences plc (LON:PRM)’s stock price traded up 45.5% on Wednesday . The company traded as high as GBX 2.50 and last traded at GBX 2.40. 1,057,249 shares traded hands during mid-day trading, an increase of 338% from the average session volume of 241,283 shares. The stock had previously closed at GBX 1.65.

Proteome Sciences Stock Down 14.5%

The company has a market cap of £7.07 million, a price-to-earnings ratio of -2.12 and a beta of 0.07. The business has a 50-day simple moving average of GBX 1.90 and a two-hundred day simple moving average of GBX 2.67. The company has a quick ratio of 0.37, a current ratio of 0.20 and a debt-to-equity ratio of -258.66.

Proteome Sciences (LON:PRM) last issued its quarterly earnings data on Thursday, September 25th. The company reported GBX (0.73) earnings per share for the quarter. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.